Delta variant on the rise The delta variant of the coronavirus SARS-CoV-2 is occurring more and more often in the Netherlands.
Launch of the European project RISK-HUNT3R The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.
Effects of COVID-19 vaccination becoming increasingly visible In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.
Strong decline of tuberculosis in the Netherlands The number of tuberculosis (TB) patients in the Netherlands decreased considerably in 2017. From 887 patients in 2016 to 787 in 2017.